Compare CELC & OPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELC | OPLN |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.6B |
| IPO Year | 2017 | 2008 |
| Metric | CELC | OPLN |
|---|---|---|
| Price | $53.29 | $33.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $150.85 | $45.11 |
| AVG Volume (30 Days) | 920.9K | ★ 927.4K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.02 |
| Revenue | N/A | ★ $1,934,500,000.00 |
| Revenue This Year | N/A | $13.17 |
| Revenue Next Year | $1,921.71 | $8.60 |
| P/E Ratio | ★ N/A | $32.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.54 | $25.81 |
| 52 Week High | $151.02 | $42.69 |
| Indicator | CELC | OPLN |
|---|---|---|
| Relative Strength Index (RSI) | 30.06 | 37.27 |
| Support Level | N/A | $30.78 |
| Resistance Level | $72.76 | $35.91 |
| Average True Range (ATR) | 4.24 | 1.19 |
| MACD | -1.03 | -0.31 |
| Stochastic Oscillator | 0.16 | 7.82 |
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.